Results 31 to 40 of about 75,491 (253)

Age-standardized mortality rates related to viral hepatitis in Brazil

open access: yesBMC Infectious Diseases, 2017
Background Liver-related mortality has been increasing worldwide. We aimed to estimate the age-standardized mortality rates from viral hepatitis in Brazil. Methods The Brazilian National Death Registry was analyzed from 2008 to 2014.
Hugo Perazzo   +9 more
doaj   +1 more source

Delta infection without increase in severity of hepatitis. [PDF]

open access: yes, 1982
The findings of increased morbidity of HbsAG positive hepatitis with delta infection in a study by Dr. Smedile et al were contrary to those of studies performed by the authors. A group of 27 and a group of 41 drug abusers were examined serologically and
Arthurs, Yvonne   +4 more
core   +1 more source

Hepatitis fulminante en la Sierra Nevada: Una forma de superinfección del virus delta con el virus de la hepatitis B.

open access: yesBiomédica: revista del Instituto Nacional de Salud, 1992
Durante septiembre de 1980 a octubre de 1983, se realizó un estudio seroepidemiológico para hepatitis A y B, en 258 personas en una ciudad (Santa Marta) población de 250.000 y tres pequeños municipios (Santa Rosalía, Julio Zawady y Aracataca ...
Alvaro Villanueva   +5 more
doaj   +1 more source

HEPATITIS DELTA

open access: yesThe Professional Medical Journal, 2018
Objectives: The objective of this study is to prevalence of hepatitis delta inpatients with chronic hepatitis B infection. Study Design: Cross-sectional study. Period: Oneyear starting from February 2016 to January 2017. Setting: Patients OPD and admitted to Dowuniversity hospital and Zubaida Medical Center Karachi. Methods: Hepatitis B surface antigen(
Hafeezullah Shaikh   +3 more
openaire   +3 more sources

Hepatitis viral en la gestación

open access: yesRevista Colombiana de Obstetricia y Ginecología, 1996
La primera causa de ictericia en el embarazo es la hepatitis viral que puede ser causada por lo menos por cinco virus (A, B, C, D y E). El descubrimiento del virus de la hepatitis C y Delta prácticamente eliminó las antes denominadas Hepatitis No A No B ...
Pío Iván Gómez Sánchez
doaj   +1 more source

Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV

open access: yesJHEP Reports, 2023
Background & Aims: Bulevirtide (BLV) is a small lipopeptide agent that specifically binds to the sodium taurocholate cotransporting polypeptide (NTCP) bile salt transporter and HBV/HDV receptor on the surface of human hepatocytes and inhibits HDV and
Roberto Mateo   +21 more
doaj   +1 more source

The prevalence of occult hepatitis B virus (hbv) infection in a large multi-ethnic haemodialysis cohort. [PDF]

open access: yes, 2015
Haemodialysis patients are at increased risk of exposure to blood borne viruses. To reduce transmission in the UK, all haemodialysis patients are regularly screened, and if susceptible to Hepatitis B virus (HBV) infection ...
Cross, J   +6 more
core   +1 more source

Persistence of extrahepatic hepatitis B virus DNA in the absence of detectable hepatic replication in patients with baboon liver transplants [PDF]

open access: yes, 1995
The presence of hepatitis B virus (HBV) DNA in extrahepatic tissues has been well documented. Whether HBV DNA can persist in extrahepatic tissues for long periods of time in the absence of replication in the liver has not been determined previously ...
Davidson   +19 more
core   +1 more source

Hepatitis Delta Virus

open access: yesIntervirology, 1991
The purpose of this article is to give a concise update on our understanding of hepatitis delta virus (HDV). For more extensive background information the reader is directed to published reviews [1-5].
openaire   +4 more sources

Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response. [PDF]

open access: yes, 2019
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide and confers a poor prognosis. Beyond standard systemic therapy with multikinase inhibitors, recent studies demonstrate the potential for robust and durable responses ...
Fong, Lawrence   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy